Sunesis Pharmaceuticals Inc., of South San Francisco, was issued a notice of allowance for a patent claiming certain compositions related to the company's lead drug candidate, vosaroxin, as well as the final product related to such compositions

VistaGen Therapeutics Inc., of South San Francisco, received two patents: U.S. Patent No

Sunesis Pharmaceuticals Inc., of South San Francisco, received U.S. Patent No

Five Prime Therapeutics Inc., of San Francisco, received U.S. Patent No

Poniard Pharmaceuticals Inc., of South San Francisco, was granted and reissued a composition-of-matter patent for picoplatin, including additional claims specific to the compound and its use in treating any type of cancer

Hana Biosciences Inc., of South San Francisco, received a notice of allowance for a pent covering the use of menadione in preventing and treating skin rash in patients taking biologic and small-molecule epidermal growth factor receptor inhibitors

Titan Pharmaceuticals Inc., of South San Francisco, received a notice of allowance for a patent application, titled "Implantable polymeric device for sustained release of buprenorphine

AvidBiotics Corp., of South San Francisco, was issued U.S. Patent No

Alios BioPharma Inc., of South San Francisco, received U.S. Patent No

Sutro Biopharma Inc., of South San Francisco, was issued patents Nos

VIA Pharmaceuticals Inc., of San Francisco, received U.S. Patent No

Inverseon Inc., of San Francisco, received notice of allowance of a U.S

DiObex Inc., of San Francisco, was granted U.S. Patent No

VIA Pharmaceuticals Inc., of San Francisco, received a patent, titled "Cyclic Nucleotide Phosphodiesterase Inhibitors, Preparation and Uses Thereof," which cover compounds that exhibit phosphodiesterase inhibition, principally PDE4 inhibition, and might be active in certain PDE subtypes

diaDexus Inc., of South San Francisco, received U.S. Patent No

Monogram Bioscience Inc., of South San Francisco, received a notice of allowance for a patent covering the use of its eTag technology for detecting protein dimers

Monogram Biosciences Inc., of South San Francisco, received notices of allowance for patents related to the use of its phenotypic technology for assessing the efficacy of HIV entry inhibitors

DiaDexus Inc., of South San Francisco, was issued U.S. Patent No

Sirna Therapeutics Inc., of San Francisco, was granted U.S. Patent No